MEDP Medpace Holdings, Inc.

633.98USD-1.99%Mkt Cap: 17.73B USDP/E: 35.20

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap17.73B USD
Enterprise Value17.56B USD
Revenue (TTM)2.84B USD
Gross Profit760.62M USD
Net Income (TTM)451.12M USD
Revenue/Share100.62 USD
Last Price633.98 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees6.6K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)35.20
P/E (Forward)31.93
PEG3.36
EV/EBITDA27.68
EV/Revenue6.19
P/S6.25
P/B30.31
EPS (TTM)18.01 USD
EPS (Forward)19.85 USD
52W Range
373.0081% of range693.72
52W High693.72 USD
52W Low373.00 USD
Profitability
Gross Margin30.06%
Oper. Margin21.39%
EBITDA Margin22.35%
Profit Margin17.83%
ROE98.27%
ROA22.84%
ROIC588.03%
ROCE84.68%
Growth
Revenue Growth8.50%
Earnings Growth25.40%
Cash Flow & Leverage
Operating CF713.22M USD
CapEx (TTM)31.36M USD
FCF Margin17.54%
FCF Yield2.81%
Net Debt-533.86M USD
Net Debt/EBITDA-0.84
Net Debt/FCF-1.07
Balance Sheet
Debt/Equity0.25
Current Ratio0.83
Quick Ratio0.77
Book Value/Sh20.92 USD
Cash/Share25.21 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)651.31 USD
Upside (mean)+2.7%
Target Range370.00 USD – 730.00 USD
370.00+2.7% to mean730.00
# Analysts13
Ownership
Shares Out.27.97M
Float22.73M
Insiders18.66%
Institutions85.25%
Short Interest
Short Ratio4.2d
Short % Float6.17%
Short % Out.4.95%
Shares Short1.38M
Short (prev mo.)1.60M
Technical
SMA 50630.66 (+0.5%)
SMA 200532.34 (+19.1%)
Beta1.11
S&P 52W Chg12.08%
Avg Vol (30d)275.27K
Avg Vol (10d)200.66K
Technical Indicators
RSI (14)44.9
MACD3.5056
MACD Signal7.8643
MACD Hist.-4.3586
BB Upper689.15 USD
BB Middle659.68 USD
BB Lower630.22 USD
BB Width8.93%
ATR (14)19.23 USD
Vol Ratio (20d)0.66x

About Medpace Holdings (NASDAQ: MEDP)

›

Medpace Holdings (NASDAQ: MEDP) is listed on Nasdaq, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 6,600 employees.

The shares were at 633.98 USD on 19 November 2026, up 7.1% over 52 weeks. Its 52-week range is 373.00 USD to 693.72 USD: the price is 8.6% below the high and 70.0% above the low.

At a market capitalisation of 17.73B USD, it trades at 35.2 times trailing earnings and 31.9 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.5, so MEDP is valued in line with them.

Medpace Holdings reports return on equity of 98.3%, an operating margin of 21.4% and revenue up 8.5% year over year.

It holds more cash than debt, a net cash position of 533.86M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 13 analysts cover the stock; their mean price target of 651.31 USD is 2.7% above the current price. The next earnings report is expected on 8 February 2027.